December 14, 2023
Biosimilar manufacturers of the major cancer drug Avastin (bevacizumab) said on December 13 that they have obtained an additional indication of malignant glioma for their follow-on versions in Japan. The products that earned the label expansions are Pfizer’s Bevacizumab BS...read more